News

Stop TB ACSM Releases New Advocacy Guide

The ACSM Subgroup of the Stop TB Partnership released a new guide to country-level best practices for advocacy, communications and social mobilization.

> click here to download the report (.pdf – 3,800kb)

From the report:

ACSM Advocacy Report
ACSM Advocacy Report

This document contains good practice examples of country-level Advocacy, Communication and Social Mobilization (ACSM) submitted by the following organizations and entities: Project PACS (Programa de Agentes Comunitários de Saúde) (Brazil), National TB Control Programme (NTP) and Programme d’Appui au Monde Associatif et Communautaire
(PAMAC) (Burkina Faso), PATH (Cambodia), Profamilia (Dominican Republic), Foundation Alli Causai (Ecuador),
Ghana Stop TB Partnership (Ghana), Operation ASHA (India), Family Health International (Malawi), Project Concern International (Mexico), Centre for Health Policies and Studies (Moldova), Provincial Health Office, Malolos, Bulacan Province (Philippines), Catholic Relief Services – United States Catholic Conference of Bishops (Philippines), HealthRight International (Romania), National TB Control Programme (Sudan), Project HOPE (Tajikistan), PATH (Ukraine).

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...